Skip to content
LauréoBetaPublic procurement intelligence
Settings
My account

XOFIGO Radium 223 pour traitement du cancer de la prostate

Source: SEAO

Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke - CHUS · Direct award · closing date not published

Facts

Published
May 19, 2022
Time to award
Closing date not published
Contract nature
Goods
Place of performance
Estrie
Documented stages
Contract termination
Value
— not declared
Reference
Notice no. 2022-1937
UNSPSC
51000000Produits pharmaceutiques, médicaments, contraceptifs et vaccins
SEAO category
G21 — Fourniture et équipement médicaux et produits pharmaceutiques

SEAO, Données Québec · data as of October 4, 2026

Description

the source is silent — Description not included in the open dataset — it remains on the notice at SEAO.

Precedents — this code at this buyer

Where do these figures come from?
reserved · subscriptionViews used up for this month: this block opens with an account.

Bidders

the source is silent — The source publishes no bidders for this notice.

The price to beat

the source is silent — The open dataset publishes no submitted amount for this public tender.

Contracting authority history — most recent awards

Where do these figures come from?
reserved · subscriptionViews used up for this month: this block opens with an account. Free with an account

Award

Winners and awarded amounts
YearWinnerValue
2022Bayer Inc.$340,000declared
Signed contracts and their end dates
ContractSignedEnd dateContract amount
2644572The signed contract falls below the awarded amount by $277,960 — −81.8%. A gap is a fact, not a judgement: across 121,996 comparable pairs it exists in 62% of cases, and half of them are below the awarded amount.2022June 11, 2023$62,040declared

SEAO, Données Québec · data as of October 4, 2026

Documents

the source is silent — No document in the open dataset · SEAO notice

Similar open notices

the source is silent — No Québec notice still open under 51000000.

Cite this page
Permalink
https://www.laureo.ca/en/avis/ocds-ec9k95-1592737
Citation
Lauréo, “XOFIGO Radium 223 pour traitement du cancer de la prostate”, Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke - CHUS, notice no. 2022-1937, data as of October 4, 2026, from SEAO / Données Québec (CC-BY 4.0). https://www.laureo.ca/en/avis/ocds-ec9k95-1592737
Reuse
Figures and text reusable with attribution. SEAO documents are never redistributed: they are linked to their official source.
Report an error
XOFIGO Radium 223 pour traitement du cancer de la prostate — Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke - CHUS — Lauréo